SNNAF yields 3159.56% · JNJ yields 2.13%● Live data
📍 SNNAF pulled ahead of the other in Year 1
Combined, SNNAF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNNAF + JNJ for your $10,000?
Sienna Resources Inc. engages in the identification, acquisition, and exploration of mineral properties in Canada, Sweden, Finland, Norway, and the United States. The company primarily explores for platinum, palladium, nickel, copper, cobalt, and lithium deposits. It holds interests in the Slättberg project located in southern Sweden. The company also holds interests in Kuusamo PGE-Ni-Cu-Co project, Finland; Clayton Valley Deep Basin Lithium Brine project, North America; and Marathon North Platinum-Palladium Property covering an area of approximately 16,500 acres and located in Northern Ontario, Canada. In addition, it holds interest in the Blue Clay lithium project covering an area of approximately 2,950 acres located in the Clayton Valley of Nevada; and White Gold project located in Yukon, Canada. The company was formerly known as Habanero Resources Inc. and changed its name to Sienna Resources Inc. in January 2014. Sienna Resources Inc. was incorporated in 1983 and is headquartered in Vancouver, Canada.
Full SNNAF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.